Informative method to identify biomarkers for guiding therapy decisions
Thursday, January 14, 2010 - 17:14
in Health & Medicine
A randomized biomarker-stratified design, which uses the biomarker to guide analysis but not treatment assignment, provides a rigorous assessment of the utility of a potential biomarker for guiding therapy, according to a commentary published online January 14 in the Journal of the National Cancer Institute.